1. Home
  2. SMID vs UNCY Comparison

SMID vs UNCY Comparison

Compare SMID & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smith-Midland Corporation

SMID

Smith-Midland Corporation

SELL

Current Price

$24.68

Market Cap

117.7M

Sector

Industrials

ML Signal

SELL

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$3.75

Market Cap

100.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMID
UNCY
Founded
1960
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.7M
100.6M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
SMID
UNCY
Price
$24.68
$3.75
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $28.40
AVG Volume (30 Days)
6.7K
★ 1.1M
Earning Date
11-16-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 62.76
N/A
EPS
★ 0.51
N/A
Revenue
★ $93,446,000.00
$675,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10,044.55
P/E Ratio
$46.96
★ N/A
Revenue Growth
★ 19.03
N/A
52 Week Low
$20.89
$3.33
52 Week High
$40.00
$8.74

Technical Indicators

Market Signals
Indicator
SMID
UNCY
Relative Strength Index (RSI) 61.71 40.82
Support Level $23.51 $3.35
Resistance Level $25.25 $4.18
Average True Range (ATR) 0.66 0.25
MACD 0.36 0.03
Stochastic Oscillator 88.96 38.84

Price Performance

Historical Comparison
SMID
UNCY

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.

Share on Social Networks: